...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Cytotoxicity of Crude Extract and Isolated Constituents of the Dichrostachys cinerea Bark towards Multifactorial Drug-Resistant Cancer Cells
【24h】

Cytotoxicity of Crude Extract and Isolated Constituents of the Dichrostachys cinerea Bark towards Multifactorial Drug-Resistant Cancer Cells

机译:Dichrostachys Cinerea Bark的粗提取物和分离成分的细胞毒性朝向多学会耐药性癌细胞

获取原文

摘要

The effectiveness of anticancer chemotherapy is greatly impeded by the resistance of malignant cells to cytotoxic drugs. In this study, the cytotoxicity of the crude extract (DCB) and compounds isolated from the bark of Dichrostachys cinerea, namely, betulinic acid (1), glyceryl-1-hexacosanoate (2), 7-hydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one (3), and 6-hydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one (4), was investigated. The study was extended to the assessment of the mode of induction of apoptosis by DCB and compound 1. The resazurin reduction assay was used for cytotoxicity studies. Assessments of cell cycle distribution, apoptosis, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS) were performed by flow cytometry. Constituents of DCB were isolated by column chromatography. Triterpenoid 1 and flavone 4 had cytotoxic effects towards the 9 tested cancer cell lines with IC50 values below 50 μM. The recorded IC50 values varied from 7.65 μM (towards multidrug-resistant CEM-ADR5000 leukemia cells) to 44.17 μM (against HepG2 hepatocarcinoma cells) for 1, 18.90 μM (CCRF-CEM leukemia cells) to 88.86 μM (against HCT116p53+/+ colon adenocarcinoma cells) for 4, and 0.02 μM (against CCRF-CEM cells) to 122.96 μM (against CEM/ADR5000 cells) for doxorubicin. DCB induced apoptosis in CCRF-CEM cells mostly mediated by MMP alteration and enhanced ROS production; compound 1 induced apoptosis through caspases activation and MMP alteration and increased ROS production. Dichrostachys cinerea is an interesting cytotoxic plant and deserves more studies leading to new antineoplastic agents to fight cancer and mostly leukemia.
机译:通过恶性细胞对细胞毒性药物的抗性大大阻碍了抗癌化疗的有效性。在这项研究中,粗提取物(DCB)的细胞毒性和从Dichrostachys的树皮中分离的化合物,即桦木酸(1),甘油-1-六烷烷(2),7-羟基-2-(4-羟基苯基研究了-4H-色度-4-一(3)和6-羟基-2-(4-羟基苯基)-4H-铬-4-一(4)。该研究扩展到DCB和化合物1对诱导凋亡的诱导方式的评估。转塔蛋白还原测定用于细胞毒性研究。通过流式细胞术进行细胞周期分布,细胞凋亡,线粒体膜电位(MMP)和反应性氧物质(ROS)的评估。通过柱色谱分离DCB的成分。三萜1和黄酮4对9个测试的癌细胞系具有细胞毒性作用,IC50值低于50μm。记录的IC50值从7.65μm(朝向多药CEM-ADR5000白血病细胞)变化至44.17μm(针对HepG2肝癌细胞)1,18.90μm(CCRF-CEM白血病细胞)至88.86μm(针对HCT116P53 + / +结肠腺癌细胞)4,和0.02μm(抗CCRF-CEM细胞)至122.96μm(针对CEM / ADR5000细胞)用于多柔比星。 DCB诱导CCRF-CEM细胞的细胞凋亡,主要由MMP改变和增强的ROS生产介导;化合物1通过半胱氨酸激活和MMP改变诱导细胞凋亡并增加ROS生产。 Dichrostachys Cinerea是一个有趣的细胞毒性植物,值得更多的研究导致新的抗肿瘤剂来对抗癌症和大多是白血病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号